GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features.
Wang T, Feldman AL, Wada DA, Lu Y, Polk A, Briski R, Ristow K, Habermann TM, Thomas D, Ziesmer SC, Wellik LE, Lanigan TM, Witzig TE, Pittelkow MR, Bailey NG, Hristov AC, Lim MS, Ansell SM, Wilcox RA.
Wang T, et al. Among authors: wellik le.
Blood. 2014 May 8;123(19):3007-15. doi: 10.1182/blood-2013-12-544809. Epub 2014 Feb 4.
Blood. 2014.
PMID: 24497534
Free PMC article.